Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 3Other solid neoplasm 1

Conditions

Carcinoma, Basal Cell 2Basal Cell Nevus Syndrome 2Solid Tumor 1Neoplasms 1Keratosis, Actinic 1

Interventions

Cyclophosphamide 910Carboplatin 787pembrolizumab 746Paclitaxel 744Bevacizumab 716Cisplatin 708Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 338Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × tazarotene × Clear all
NCT04071756 2024-02-07

Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions

Dana-Farber Cancer Institute

Phase 2 Terminated
8 enrolled 12 charts
Other solid neoplasm

Solid Tumor

NCT00489086 2020-10-29

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face

UCSF Benioff Children's Hospital Oakland

Phase 2 Completed
36 enrolled 7 charts
Dermatologic

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell, Neoplasms

NCT00783965 2016-02-11

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back

UCSF Benioff Children's Hospital Oakland

Phase 2 Completed
34 enrolled 9 charts
Dermatologic

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT01053000 2015-08-11

Photodynamic Therapy With Levulan® +/- Topical Retinoid Pre-Treatment In The Treatment Of Actinic Keratoses

Stewart, Roger H., M.D., P.A.

Phase NA Completed
10 enrolled 5 charts
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡